Martine Rothblatt has made no secret of her goal to move beyond the pharmaceutical business model that made her first foray into the biotech world — United Therapeutics Corp. (NASDAQ: UTHR) — a striking success.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2016/07/martine-rothblatt-on-human-organ-manufacturing.html?ana=e_du_pap&s=article_du&ed=2016-07-21&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1469132146&j=75057922{/iframe}